STOCK TITAN

[8-K] JOHNSON & JOHNSON Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Johnson & Johnson filed a Form 8-K to share that it has issued a press release announcing its sales and earnings for the fourth quarter and full year ended December 28, 2025. The filing states that the press release is attached as Exhibit 99.1 and covers both quarterly and annual performance.

The company also attached unaudited comparative supplementary sales data and a condensed consolidated statement of earnings for the same periods as Exhibit 99.2. This 8-K centers on making these earnings materials publicly available rather than detailing the specific financial results within the form itself.

Positive

  • None.

Negative

  • None.
0000200406false00002004062026-01-212026-01-210000200406us-gaap:CommonStockMember2026-01-212026-01-210000200406jnj:A1.150NotesDueNovember2028Member2026-01-212026-01-210000200406jnj:A2.700NotesDueFebruary2029Member2026-01-212026-01-210000200406jnj:A3.20NotesDueJune2032Member2026-01-212026-01-210000200406jnj:A3.050NotesDueFebruary2033Member2026-01-212026-01-210000200406jnj:A1.650NotesDueMay2035Member2026-01-212026-01-210000200406jnj:A3.350NotesDueJune2036Member2026-01-212026-01-210000200406jnj:A3.350NotesDueFebruary2037Member2026-01-212026-01-210000200406jnj:A3.550NotesDueJune2044Member2026-01-212026-01-210000200406jnj:A3.600NotesDueFebruary2045Member2026-01-212026-01-210000200406jnj:A3.700NotesDueFebruary2055Member2026-01-212026-01-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): 
January 21, 2026
Johnson & Johnson
(Exact name of registrant as specified in its charter)
New Jersey1-321522-1024240
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
One Johnson & Johnson Plaza, New Brunswick, New Jersey  08933 
(Address of Principal Executive Offices)
 (Zip Code) 
Registrant's telephone number, including area code:
732-524-0400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, Par Value $1.00JNJNew York Stock Exchange
1.150% Notes Due November 2028JNJ28New York Stock Exchange
2.700% Notes due February 2029JNJ29BNew York Stock Exchange
3.200% Notes Due June 2032JNJ32New York Stock Exchange
3.050% Notes due February 2033JNJ33BNew York Stock Exchange
1.650% Notes Due May 2035JNJ35New York Stock Exchange
3.350% Notes Due June 2036JNJ36ANew York Stock Exchange
3.350% Notes due February 2037JNJ37BNew York Stock Exchange
3.550% Notes Due June 2044JNJ44New York Stock Exchange
3.600% Notes due February 2045JNJ45New York Stock Exchange
3.700% Notes due February 2055JNJ55New York Stock Exchange



Item 2.02 Results of operations and financial condition
On January 21, 2026, Johnson & Johnson (the “Company”) issued the attached press release (Exhibit 99.1) announcing its sales and earnings for the fourth quarter and full year ended December 28, 2025.
Item 9.01 Financial statements and exhibits
(d)    Exhibits.
Exhibit No.Description of Exhibit
99.1
Press Release dated January 21, 2026 for the period ended December 28, 2025
99.2
Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings for the fiscal fourth quarter and full year
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.



Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 21, 2026
JOHNSON & JOHNSON
(Registrant)
By:
/s/ Robert J. Decker, Jr.
Robert J. Decker, Jr.
Controller
(Principal Accounting Officer)

Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Latest SEC Filings

JNJ Stock Data

525.25B
2.41B
0.06%
74.37%
0.78%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NEW BRUNSWICK